Growth factor control of developing kidney endothelial cells

Experimental Nephrology

Volumn 4, Issue 2, 1996, Pages 112-118

  Loughna, Siobhan ^a   Landels, Eleanor ^a   Woolf, Adrian S ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR;

ANATOMY; ANGIOGENESIS; ENDOTHELIUM; GENE EXPRESSION; HUMAN; KIDNEY DEVELOPMENT; ORGANOGENESIS; PRIORITY JOURNAL; REVIEW;

ANIMALS; BLOOD VESSELS; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; GROWTH SUBSTANCES; HUMANS; KIDNEY; LYMPHOKINES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0029916782     PISSN: 10187782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Holliday MA, Barratt TM, Avner E: Pediatric Nephrology. Baltimore, Williams & Wilkins, 1994.
2. Pardanaud L, Yassine F, Dieterlen-Lièvre F: Relationship between vasculogenesis, angio-genesis and haematopoiesis during avian ontogeny. Development 1989;105:473-485.
3. Bernstein J, Cheng F, Roszka J: Glomerular differentiation in metanephric culture. Lab Invest 1981;45:183-190.
4. Sariola H, Ekblom P, Lehtonen E, Saxen L: Differentiation and vascularisation of the metanephric kidney grafted on the chorioallantoic membrane. Dev Biol 1983;96:427-435.
5. Brogi E, Wu T, Namiki A, Isner JM: Indirect angiogenetic cytokines upregulate VEGF and bFGF expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. Circulation 1994;90:649-652.
6. Tuder RM, Flook BE, Voelkel NF: Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Fit in lungs exposed to acute or chronic hypoxia: Modulation of gene expression by nitric oxide. J Clin Invest 1995; 95:1789-1807.
7. O'Reilly MS, Holmgren L, Shing L, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH, Folkman J: Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 1994;79:315-328.
8. Landels E, Proschel C, Noble MD, Jat PS, Fine LG, Woolf AS: Receptor tyrosine kinases expressed in early nephrogenesis (abstract). J Am Soc Nephrol 1994;5:245.
9. Loughna S, Hardman P, Woolf AS: Vascular endothelial growth factor receptors are expressed in metanephric mesenchyme and epithelium (abstract). J Am Soc Nephrol 1995;6: 702.
10. Pinson DY, St. John PL, Tucker DC, Abrahamson DR: Origin of glomenilar microvasculature in kidneys developing in oculo (abstract). J Am Soc Nephrol 1993;4:474.
11. Sariola H, Timpl R, von der Mark K, et al: Dual origin of glomerular basement membrane. Dev Biol 1984;101:86-98.
12. Woolf AS, Palmer SJ, Snow ML, Fine LG: Creation of a functioning chimeric mammalian kidney. Kidney Int 1990;38:991-997.
13. Millauer B, Wizigmann-Voos S, Schnurch H, Martinez R, Moller NPH, Risau W, Ullrich A: High-affinity VEGF binding and developmental expression suggest flk1 as a major regulator of vasculogcnesis and angiogenesis. Cell 1993;72:835-846.
14. Breier G, Albrecht U, Sterrer S, Risau W: Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development 1992; 114:521-532.
15. Roberts WG, Palade GE: Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci 1995;108:2369-2379.
16. Flamme J, Breier G, Risau W: Vascular endothelial growth factor (VEGF) and VEGF receptor 2 (flk-1) are expressed during vasculogenesis and vascular differentiation in the quail embryo. Dev Biol 1995;169:699-712.
17. Iijima K, Yoshokawa N, Connolly DT, Nakamura H: Human mesangial cells and peripheral blood mononuclear cells produce vascular permeability factor. Kidney Int 1993;44:959-966.
18. Millauer B, Shawver LK, Plate KH, Risau W, Ullrich A: Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature 1994;367:576-579.
19. Oberg C, Waltenberger J, Claesson-Welsh L, Welsh M: Expression of protein tyrosine kinases in islet cells:: Possible role of the flk-1 receptor for β-cell maturation from duct cells. Growth Factors 1994;10:115-126.
20. Charnock-Jones DS, Sharkey AM, Boocock CA, Ahmed A, Pelvin R, Ferrara N, Smith SK: Vascular endothelial growth factor receptor localisation and activation in human trophoblast and choriocarcinoma cells. Biol Reprod 1994; 51:524-530.
21. Midy V, Plouet J: Vasculotropin/vascular endothelial growth factor induces differentiation of cultured osteoblasts. Biochem Biophys Res Commun 1994;199:380-386.
22. Shalaby F, Rossant J, Yamaguchi TP, Gerstenstein M, Wu X-F, Breitman ML, Schuh AC: Failure of blood island formation and vasculo-genesis in flk-1 deficient mice. Nature 1995; 376:62-66.
23. Fong G-H, Rossant J, Gerstenstein M, Breitman ML: Role of the flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 1995;376:66-74.
24. Oelrichs R, Reid HH, Bernard O, Ziemiecki A, Wilks A: NYK/FLK-1: A putative receptor tyrosine kinase isolated from E10 embryonic neuroepithelium is expressed in endothelial cells of the developing embryo. Oncogene 1992;8:11-18.
25. Kaipainen A, Korhonen, Pajusola K, Aprelikova O, Persico MG, Terman BI, Alitalo K: The related FLT4, FLT1, and KDR receptor tyrosine kinases show distinct expression patterns in human fetal endothelial cells. J Exp Med 1993;178:2077-2088.
26. Simon M, Grone H-J, Johren O, Kullmer J, Plate HK, Risau W, Fuchs E: Expression of vascular endothelial growth factor and its receptors in human renal ontogenesis and in adult kidney. Am J Physiol 1995;268:F240-F250.
27. Brown LF, Berse B, Tognazzi K, Manseau EJ, Van de Water, Senger DR, Dvorak HF, Rosen S: Vascular permeability factor mRNA and protein expression in human kidney. Kidney Int 1992;42:1457-1461.
28. Takahashi T, Shirsawa T, Miyake K, Yahagi Y, Maruyama N, Kasahara N, Kawamura T, Matsumura O, Mitarai T, Sakai O: Protein tyrosine kinases expressed in glomeruli and cultured glomerular cells: Flt-1 and VEGF expression in renal mesangial cells: Biochem Biophys Res Commun 1995;209:218-226.
29. Uchida K, Uchida S, Nitta K, Yumura W, Marumo F, Nihei H: Glomerular endothelial cells in culture express and secrete vascular endothelial growth factor. Am J Physiol 1994; 266:F81-F88.
30. Sato TN, Tozawa Y, Deutsch U, Wolburg-Buchholz K, Fujiwara Y, Gendron-Maguire M, Gridley T, Wolburg H, Risau W, Qin Y: Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 1995;376:70-74.
31. Dumont DJ, Gradwohl G, Fong G-H, Puri MC, Gerstenstein M, Auerbach A, Breitman ML: Dominant-negative and target null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis in the embryo. Genes Dev 1994;8:1897-1909.
32. Dickson MC, Martin JS, Cousins FM, Kulkarni AB, Karsson S, Akhurst RJ: Defective haematopoiesis and vasculogenesis in transforming growth factor-β I knock out mice. Development 1995;121:1845-1854.
33. Soriano P: Abnormal kidney development and hematological disorders in platelet-derived growth factor β-receptor mutant mice. Genes Dev 1994;8:1888-1896.
34. Grant DS, Kleinman HK, Goldberg ID, Bhargava MM, Nickoloff BJ, Kinsella JL, Polverini P, Rosen EM: Scatter factor induces blood vessel formation in vivo. Proc Natl Acad Sci USA 1993;90:1937-1941.
35. Schreiber AB, Winkler ME, Derynck R: Transforming growth factor-α: A more potent angio-genic mediator than epidermal growth factor. Science 1986;232:1250-1253.
36. Woolf AS, Kolatsi-Joannov M, Hardman P, Andermarcher E, Moorby C, Fine LG, Jat PS, Noble MD, Gherardi E: Roles of hepatocyte growth factor/scatter factor and met in early development of the metanephros. J Cell Biol 1995;128:171-184.